(Sharecast News) - Futura Medical warned on Friday that full-year revenue was set to be "materially below expectations" following a review of forecast revenue streams.
The AIM-listed consumer healthcare firm, which is behind erectile dysfunction treatment Eroxon, said in-market sales of the latter have been slower than originally expected.

This...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE